700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02169

Synthetic patientMETA-24 · Day 179 · 55–64 · M · baseline S17Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
8%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S17
  2. Day 11 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 11.

Primary contributors, last 14 days
  • GI instability-12
  • Treatment adherence+5
  • Toxicity+5
  • Nutritional resilience+4
  • Inflammatory activity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    54 min
    worsening · -6.0 vs previous 14 d
    Sleep duration
    Wearable
    6.6 h
    stable · -0.1 vs previous 14 d
    Energy level
    Daily log
    6.5/10
    improving · +0.3 vs previous 14 d
    Steps
    Wearable
    5,801
    worsening · -297 vs previous 14 d
    GI burden
    Companion
    13.3/100
    improving · -1.5 vs previous 14 d
    Adherence
    Companion
    96.1 %
    stable · +0.7 vs previous 14 d
    Sleep quality
    Wearable
    49.2/100
    stable · +0.5 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    135 mg/dL
    stable · -3.1 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards restoration · 74 from the failing basin, 35 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    • More protein
      GI -3.9 next day on high-intake days · n 19
    Would not help
    • BR-03 Behavioural Recommendation
      only 22% improved among 9 similar
    • Keep fat low
      GI +3.5 next day on high-intake days · n 13
    • Keep ultra-processed low
      GI +3.2 next day on high-intake days · n 17
    • Keep simple carbs low
      GI +2.4 next day on high-intake days · n 14
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.9supporter · 95%
    • Dietary fat load
      +3.5detractor · 95%
    • Ultra-processed food
      +3.2detractor · 95%
    • Simple carbohydrates
      +2.4detractor · 85%
    • Histamine load
      -1.2no signal · 37%
    • Alcohol
      +1.2no signal · 30%
    • Caffeine
      +0.7no signal · 16%
    • Insoluble fibre
      +0.5no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production ↓35
      • MicrobiomeButyrate capacity 23/100
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Inflammatory signalling ↓25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.7 · butyrate capacity 23/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    44 ms
    Sleep
    6.4 h
    Steps
    5,102
    Resting HR
    62 bpm
    Daily log: GI score 13, nutritional resilience 66, adherence 96.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0249457%S09GI-04improved47
    P-0220054%S13——47
    P-0230354%S15GI-04improved48
    P-0251352%S16GI-04no change46
    P-0203351%S06GI-04improved51
    P-0245551%S09DT-01improved50
    P-0257350%S10——52
    P-0207048%S11——55
    P-0223548%S14DT-01improved50
    P-0233648%S20——50
    P-0264548%S02HY-01improved56
    P-0213047%S20——49